ADA Issues New Standards of Medical Care for Diabetes
Standards include new recommendations for statin treatment based on individual risk profile
WEDNESDAY, Dec. 24, 2014 (HealthDay News) -- New standards of care have been issued by the American Diabetes Association (ADA) and published as a supplement to the January issue of Diabetes Care.
Researchers reviewed the Standards of Medical Care in Diabetes for 2015, focusing on revisions to clinical practice recommendations.
The researchers note that all individuals, including those with diabetes, should be encouraged to limit the amount of sedentary time by breaking up extended amounts of time (more than 90 minutes) spent sitting. Premeal blood glucose targets were revised to reflect new data. With respect to cardiovascular disease and risk management, the recommended goal for diastolic blood pressure was changed from 80 to 90 mm Hg for most people with diabetes and hypertension. Recommendations for statin treatment and lipid monitoring were changed; initiation of treatment and initial statin dose are now recommended primarily based on risk status. Based on the new recommendations, lipid monitoring guidelines suggest a screening lipid profile at diabetes diagnosis, at an initial medical evaluation, and/or at age 40 years, and periodically thereafter.
"The big change here is to recommend starting either moderate- or high-intensity statins based on the patient's risk profile rather than on low-density lipoprotein level," Richard W. Grant, M.D., M.P.H., a research scientist in the Kaiser Permanente Division of Research and chair of the ADA's Professional Practice Committee, said in a statement.
Several authors of the report disclosed financial ties to the pharmaceutical industry.